Toxicities associated with immunotherapy warrant ‘very high level of suspicion’ – Healio
|
Toxicities associated with immunotherapy warrant 'very high level of suspicion'
Healio Since 2011, the FDA has approved six immune checkpoint inhibitors designed to reverse the course of multiple cancers. Those approvals — along with oncologists' willingness to combine immunotherapies — has led to more durable responses among patients … |
